Yorba Linda, Ca (PRWEB) December 16, 2016
1,25-Dihydroxyvitamin D (1,25[OH]2D) is the active, hormonal form of vitamin D. Circulating 1,25(OH)2D levels are regulated by serum calcium and phosphate concentrations; this is mediated by the calcium-regulating hormones. In the human body, 1,25(OH)2D has a broad range of actions which include endocrine, autocrine and paracrine properties.
Due to its picomolar concentrations and its lipophilic nature, 1,25(OH)2D is a difficult analyte and represents a challenge to the analytical biochemist with respect to quantification. Until recently, relatively large sample volumes and extensive purification and separation steps were required to quantify 1,25(OH)2D. In this webinar, sponsored by DiaSorin, participants will learn the clinical relevance of circulating 1,25(OH)2D. Besides the well-known suppression of circulating 1,25(OH)2D in chronic kidney disease, it will become evident that circulating 1,25(OH)2D is also reduced in other diseases.
In the clinical setting, however, there are still several gaps in the present knowledge on circulating 1,25(OH)2D. This webinar will delve into these gaps, which include incomplete data about the effect of activated vitamin D; the influence of dosing and initial 25OHD level on circulating 1,25(OH)2D; and the effect of different diseases on circulating 1,25(OH)2D.
Attendees will learn the clinical conditions that would benefit from follow-up measurement for 1,25 dihydroxyvitamin D, as well as better understand why active vitamin D therapy should be accompanied by measuring 1,25 dihydroxyvitamin D.
The speaker for this webinar will be Dr. Armin Zittermann, head of the Center for Clinical Studies in Thoracic and Cardiovascular Surgery at the Heart and Diabetes Center.
As a nutritionist and head of the Center for Clinical Studies in Thoracic and Cardiovascular Surgery at the Heart and Diabetes Center in Bad Oeynhausen, Germany, Zittermann’s research focuses on the prevalence and the consequences of insufficient levels of vitamin D in humans, in particularly in patients with cardiovascular diseases. Zittermann also lectures at the Institute of Nutrition and Food Sciences at the University of Bonn on specific aspects of food security.
LabRoots hosted the webinar December 7, which is now available on demand. To read full event details, learn about P.A.C.E continuing education credits, or to register for free, click here.
Headquartered in Italy and listed in the FTSE Italia Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the IVD “diagnostics specialist.”
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.